Palapas, Baby Girl .
HRN: 26-14-77 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/26/2024
01/01/2025
IV
35 Mg
Q24H
Neonate Affected By Maternal Factor Preeclampsia
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes